In a recent study, the use of anifrolumab in SLE patients was shown to be safe and effective, enabling some patients to decrease their oral steroids. Also, secukinumab has been approved in Europe to treat ankylosing spondylitis and psoriatic arthritis…
Plus, updates on arhalofenate, ALO-02, and other rheumatology drug news, safety information
Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information
Patient Centered Outcomes Research Institute executives review PCORI’s funding, research focus and the importance of including patients as partners
Inside the pathophysiology, clinical presentations of chronic pruritus
Plus, rheumatology drug news, safety updates
Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities
Toxicity and appropriate targeting are challenges for small molecule researchers